Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.

International journal of oncology

Volumn 18, Issue 3, 2001, Pages 599-606

  Mason, K ^a   Staab, A ^a   Hunter, N ^a   McBride, W ^a   Petersen, S ^a   Terry, N ^a   Milas, L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DRUG DERIVATIVE; PACLITAXEL; RADIOSENSITIZING AGENT; TAXOID;

ANIMAL; ARTICLE; C3H MOUSE; CELL SURVIVAL; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HELPER CELL; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; MUSCLE TUMOR; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; TUMOR ASSOCIATED LEUKOCYTE; WHOLE BODY RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; COMBINED MODALITY THERAPY; IMMUNE SYSTEM; IMMUNE TOLERANCE; IMMUNOCOMPETENCE; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MUSCLE NEOPLASMS; PACLITAXEL; RADIATION-SENSITIZING AGENTS; T-LYMPHOCYTES, HELPER-INDUCER; TAXOIDS; WHOLE-BODY IRRADIATION;

MLCS; MLOWN;

EID: 0035286721     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.18.3.599     Document Type: Article

References (0)